The marketing authorization holder informed its supplied customers in a letter dated June 18, 2013, that due to an individual complaint from the…

The marketing authorization holder informed its supplied customers in a letter dated June 3, 2013, that in the course of stability tests after 24…

The marketing authorization holder has informed its supplied customers in a letter dated 24.05.2013 that particles were observed in some vials. For…

During a routine test, leaks in the area of the predetermined breaking point at the neck of an amber glass ampoule of the size 1 ml were discovered in…

The marketing authorization holder informed its customers in a letter dated April 18, 2013, that due to a technical defect during production, isolated…

The marketing authorization holder has informed its supplied customers and medical home pharmacies that a microbiological contamination has been…

The distributor informed its supplied customers that during stability tests after a storage period of more than two years the specifications of the…

The marketing authorization holder has informed its supplied customers that preliminary results from the HPS2-THRIVE study (Heart Protection Study…

The marketing authorization holder informed its supplied customers in a letter dated Dec. 20, 2012, that the batch would be replaced due to unusual…

The distributor has informed its supplied customers that the above batch was intended for Germany or was placed on the market in Austria in German…